Discovering, developing & commercializing broad-spectrum antivirals

Dedicated to preventing and treating life- threatening viral infections

Innovation to address high unmet medical needs

Welcome to Chimerix

(NASDAQ: CMRX) Chimerix is a biopharmaceutical company dedicated to discovering, developing and commercializing novel, oral antivirals in areas of high unmet medical need.


Copyright © 2015 Chimerix, Inc. All rights reserved.